Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancerTodd W. Miller, Carlos L. Arteaga|Breast Cancer Research|2011Cited by 463
The receptor tyrosine kinase ErbB3 maintains the balance between luminal and basal breast epitheliumJustin M. Balko, Rebecca S. Cook, Meghan M. Morrison et al.|Proceedings of the National Academy of Sciences|2011Cited by 75
TRIM33 Is a Co-Regulator of Estrogen Receptor AlphaBianca A. Romo, Todd W. Miller|Cancers|2024Cited by 4
Endocrine persistence in ER+ breast cancer is accompanied by metabolic vulnerability in oxidative phosphorylationSteven Tau, Todd W. Miller|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 3
Combined Radiation and Endocrine Therapies Elicit Benefit in ER+ Breast CancerAnneka L. Johnson, Todd W. Miller|Cancers|2025Cited by 1